These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12018951)

  • 1. A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein.
    Garrigues A; Nugier J; Orlowski S; Ezan E
    Anal Biochem; 2002 Jun; 305(1):106-14. PubMed ID: 12018951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine modulates P-glycoprotein function.
    Orlowski S; Valente D; Garrigos M; Ezan E
    Biochem Biophys Res Commun; 1998 Mar; 244(2):481-8. PubMed ID: 9514944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
    J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction.
    Martin C; Berridge G; Higgins CF; Callaghan R
    Br J Pharmacol; 1997 Oct; 122(4):765-71. PubMed ID: 9375975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles.
    Garrigos M; Belehradek J; Mir LM; Orlowski S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1034-41. PubMed ID: 7902705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
    Orlowski S; Mir LM; Belehradek J; Garrigos M
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.
    Garrigues A; Escargueil AE; Orlowski S
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10347-52. PubMed ID: 12145328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
    Garrigos M; Mir LM; Orlowski S
    Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
    Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First characterization of fish P-glycoprotein (abcb1) substrate specificity using determinations of its ATPase activity and calcein-AM assay with PLHC-1/dox cell line.
    Zaja R; Lončar J; Popovic M; Smital T
    Aquat Toxicol; 2011 May; 103(1-2):53-62. PubMed ID: 21392495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities.
    Orlowski S; Selosse MA; Boudon C; Micoud C; Mir LM; Belehradek J; Garrigos M
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):85-110. PubMed ID: 9923970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
    Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2006 Oct; 399(2):351-9. PubMed ID: 16813563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2004 Sep; 43(38):12081-9. PubMed ID: 15379547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein and pharmacokinetics.
    Levêque D; Jehl F
    Anticancer Res; 1995; 15(2):331-6. PubMed ID: 7763002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.